Skadden advised Vertex Pharmaceuticals Incorporated on the deal while Cooley represented ViaCyte. Vertex Pharmaceuticals Incorporated (“Vertex”) has entered into a definitive agreement under which Vertex will acquire...
Vertex’s $320 Million Acquisition of ViaCyte
Halozyme Therapeutics’ Acquisition of Antares Pharma
Weil, Gotshal & Manges advised Halozyme, while Skadden, Arps, Slate, Meagher & Flom advised Antares Pharma on the deal. Fried Frank acted as counsel to BofA...
PCI Pharma Services’ Acquisition of Lyophilization Services of New England
Skadden, Arps, Slate, Meagher & Flom and Sheppard, Mullin, Richter & Hampton acted as legal advisors to the Permira Funds in the transaction. Paul, Weiss advised...
One Medical’s $2.1 Billion Acquisition of Iora Health
Skadden, Arps, Slate, Meagher & Flom advised Iora Health, while Cooley and Ropes & Gray advised One Medical on the deal. Wilson Sonsini Goodrich & Rosati...
Xeris Pharmaceuticals’ Acquisition of Strongbridge Biopharma
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
Xeris Pharmaceuticals’ Acquisition of Strongbridge Biopharma
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....